SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-116270
Filing Date
2021-04-14
Accepted
2021-04-14 16:10:53
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFA14A d170549ddefa14a.htm DEFA14A 33271
2 GRAPHIC g170549na3.jpg GRAPHIC 2378
3 GRAPHIC g170549na4.jpg GRAPHIC 2840
4 GRAPHIC g170549na5.jpg GRAPHIC 885
5 GRAPHIC g170549nanew.jpg GRAPHIC 28663
6 GRAPHIC g170549newcontrl.jpg GRAPHIC 13976
  Complete submission text file 0001193125-21-116270.txt   101948
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38981 | Film No.: 21825820
SIC: 2834 Pharmaceutical Preparations